Strong Funding Base CurePSP has a robust revenue range of $25 million to $50 million, indicating substantial financial resources that can support collaborations, sponsorships, and program sponsorships in healthcare, research, and community outreach initiatives.

Research Partnerships The organization actively partners with leading biotech companies like Biogen and technology firms such as Dthera, highlighting opportunities to develop joint research projects, clinical trials, and technological solutions for neurodegenerative disease management.

Dedicated Leadership Recent hires in leadership roles focusing on development and scientific affairs suggest openness to strategic engagement and partnership opportunities that can accelerate research, funding, and service expansion efforts.

Targeted Disease Focus With a clear focus on rare neurodegenerative diseases such as PSP, CBD, and MSA, CurePSP presents a compelling opportunity for specialized medical technology providers, patient support services, and educational initiatives tailored to these conditions.

Community Engagement Established collaborations with home care providers and advocacy groups demonstrate an active outreach to improve quality of life for affected individuals, which can be leveraged for expanding services, technology deployment, and community-based programs.